Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment

• Published in: Nutrients Vol. 14; no. 9; p. 1950
• Main Authors: Erhardt, Éva, Molnár, Dénes
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 06.05.2022; MDPI
• Subjects: Age; Appetite; Behavior; Body composition; Body fat; Body mass; Body weight gain; Calories; Carbohydrates; Child; Child, Preschool; Children; Diet; Energy expenditure; Food; Genetic disorders; Hormones; Humans; Hyperphagia; Hyperphagia - etiology; Hyperphagia - prevention & control; Hypothalamus; Infant; Lean body mass; Metabolism; Metformin; Muscles; Nutrition; nutritional phases; Obesity; Obesity, Morbid - complications; Peptides; Prader-Willi syndrome; Prader-Willi Syndrome - complications; Prader-Willi Syndrome - drug therapy; prevention; Proteins; Quality of Life; Review; Topiramate; treatment; Weight control; Weight Gain; nutritional phases; treatment; Prader–Willi syndrome; obesity; prevention
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu14091950

Prader-Willi syndrome (PWS) is a complex genetic disorder which involves the endocrine and neurologic systems, metabolism, and behavior. The aim of this paper is to summarize current knowledge on dietary management and treatment of PWS and, in particular, to prevent excessive weight gain. Growth hormone (GH) therapy is the recommended standard treatment for PWS children, because it improves body composition (by changing the proportion of body fat and lean body mass specifically by increasing muscle mass and energy expenditure), linear growth, and in infants, it promotes psychomotor and IQ development. In early childhood, the predominant symptom is hyperphagia which can lead to early onset, severe obesity with different obesity-related comorbidities. There are several studies on anti-obesity medications (metformin, topiramate, liraglutide, setmelanotide). However, these are still limited, and no widely accepted consensus guideline exists concerning these drugs in children with PWS. Until there is a specific treatment for hyperphagia and weight gain, weight must be controlled with the help of diet and exercise. Below the age of one year, children with PWS have no desire to eat and will often fail to thrive, despite adequate calories. After the age of two years, weight begins to increase without a change in calorie intake. Appetite increases later, gradually, and becomes insatiable. Managing the progression of different nutritional phases (0-4) is really important and can delay the early onset of severe obesity. Multidisciplinary approaches are crucial in the diagnosis and lifelong follow-up, which will determine the quality of life of these patients.